Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference
prnewswire.com
Want to monitor 0HT4.L?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor 0HT4.LNo company information available
No data available